← Revision 11 as of 2008-07-19 15:49:21
Size: 1968
Comment:
|
← Revision 12 as of 2008-07-19 15:53:00 →
Size: 2035
Comment:
|
Deletions are marked like this. | Additions are marked like this. |
Line 16: | Line 16: |
* Allan Kuchinsky (Agilent Technologies, San Francisco Bay area) |
Cytoscape Board Meeting
- Date: Saturday, July 19, 2008
- Time: 3:45pm-5:00pm
Place: CCBR Black Room ([http://www.cytoscape.org/cgi-bin/moin.cgi/CytoscapeRetreat2008 General location information])
Description
This is a private meeting of the Cytoscape board of directors and scientific advisory board members to discuss Cytoscape strategy, funding and scientific directions, as part of the [http://www.cytoscape.org/cgi-bin/moin.cgi/CytoscapeRetreat2008 Cytoscape retreat].
Attendees
- Trey Ideker (University of California, San Diego)
- Gary Bader (University of Toronto)
- Annette Adler (Agilent Technologies, San Francisco Bay area)
- Allan Kuchinsky (Agilent Technologies, San Francisco Bay area)
- Alex Pico (in lieu of Bruce Conklin) (Gladstone Institute of Cardiovascular Disease, UCSF, San Francisco)
- Benno Schwikowski (Institut Pasteur, Paris)
- Chris Sander (Memorial Sloan-Kettering Cancer Center, New York)
- Charlie Boone (University of Toronto)
- Mark Gerstein (Yale University)
- Shoshana Wodak (Hospital for Sick Children, Toronto)
- Yeyejide Adeleye (Unilever, UK)
- David States (University of Michigan)
Agenda
- Cytoscape Status Update (Mike Smoot, Cytoscape Chief Architect)
- Matters arising from the Cytoscape Retreat
- New secretary/treasurer (Trey)
- Cytoscape book - what's the goal? (Gary)
- More face to face core developer meetings - 3/year on west coast? (Gary)
- More open core development mailing list? (Gary)
- Funding (Trey)
- Scientific directions. Goal: create a scientific vision for Cytoscape